Prise en charge des hypertriglycéridémies et du risque de pancréatite [The management of hypertriglyceridemia and the risk of pancreatitis]

Details

Ressource 1Download: RMS_790-2_1464.pdf (818.89 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_D23403F835DB
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Prise en charge des hypertriglycéridémies et du risque de pancréatite [The management of hypertriglyceridemia and the risk of pancreatitis]
Journal
Revue medicale suisse
Author(s)
Garelli V., Pauchet A., Kissling S., Sartori C., Rodondi N., Collet T.H.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
04/03/2020
Peer-reviewed
Oui
Volume
16
Number
684
Pages
451-454
Language
french
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
In the face of hypertriglyceridemia, the potential causes must be assessed to choose the best medical therapeutic option. In cases of secondary hypertriglyceridemia, physicians should use treatments targeting the pathophysiological mechanisms underlying the lipid disorder. Lifestyle interventions are the cornerstone of an effective treatment, to achieve controlled glycemia, blood pressure and weight loss. Only in cases where these measures are insufficient, fibrates can be trialed although their clinical benefit is controversial, with special caution when combined with statins (risk of rhabdomyolysis). Plasmapheresis or intravenous insulin therapy are only used in severe situations after a multidisciplinary decision process in the hospital setting. The clinical case presented here reminds us to assess hypertriglyceridemia in the face of any acute pancreatitis.
Keywords
Acute Disease, Humans, Hypertriglyceridemia/complications, Hypertriglyceridemia/therapy, Insulin/administration & dosage, Insulin/therapeutic use, Pancreatitis/complications, Plasmapheresis
Pubmed
Create date
17/06/2020 9:24
Last modification date
20/08/2022 6:14
Usage data